Kymera Therapeutics, Inc. Common Stock
$111.95
▼ 3.86
(-3.33%)
Volume: 693,407
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
39
- 21d momentum -10.8%
- RSI 42
🎯
Pullback
62
- Near lower Bollinger band
- -4.2% vs 20MA
💎
Value
50
- No fundamental data
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)42.5
MACD-0.596
MA trendMixed
ATR4.58%
21d mom.-10.8%
63d mom.+3.5%
vs 20MA-4.2%
RVOL(20)0.95×
52w low · 54
52w high · 130
-13.9% from 52-week high
20d support 110
· resistance 124
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$9.6B
PER—
PBR6.38
PSR91.71
EPS$-3.60
ROE-19.9%
ROA-18.2%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-28.12
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -4.93% | -10.83% | +3.54% | +39.62% | +113.24% | +53.86% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -4.63%, daily vol 2.48%. Kymera Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.